A rare rarity

Elisa Giannetta, Valentina Guarnotta, Francesca Rota, Federica de Cicco, Federica Grillo, Annamaria Colao, Antongiulio Faggiano

Research output: Contribution to journalArticle

Abstract

Esophageal Neuroendocrine tumors (NETs) are rare, aggressive and lacking specific symptoms. This causes a diagnostic delay, worsening the prognosis. Numerous cases are reported in literature, without a consensus on the management. Our aim was to clarify epidemiology, clinical presentation, diagnostic, therapeutic management of esophageal NETs. Extensive literature search identified a total of 226 articles. One hundred twenty-five articles (n = 1676) met the inclusion criteria, showing that: the incidence of esophageal NET varies geographically; men (60–70 years) are more affected; smoking and alcohol abuse are the major risk factors; dysphagia, weight loss, appetite loss are the most common clinical features. The histotypes include high-grade small and large cell esophageal carcinomas and low-grade carcinoid tumors. Mixed neuroendocrine/non-neuroendocrine neoplasms are the most common. Often the diagnosis occurs randomly on endoscopic examination. Circulating markers, functional combined with conventional imaging contributes to the diagnosis and management. Treatment depends on type, grade and stage of the tumor.
Original languageEnglish
Pages (from-to)92-107
Number of pages16
JournalCritical Reviews in Oncology/Hematology
Volume137
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Neuroendocrine Tumors
Large Cell Carcinoma
Carcinoid Tumor
Appetite
Deglutition Disorders
Alcoholism
Weight Loss
Neoplasms
Consensus
Epidemiology
Smoking
Incidence
Therapeutics

Keywords

  • Esophageal NEC
  • Gastroenteropancreatic NET
  • Large cell esophageal NEN
  • MANEC
  • Small cell carcinoma

Cite this

Giannetta, E., Guarnotta, V., Rota, F., de Cicco, F., Grillo, F., Colao, A., & Faggiano, A. (2019). A rare rarity. Critical Reviews in Oncology/Hematology, 137, 92-107. https://doi.org/10.1016/j.critrevonc.2019.02.012

A rare rarity. / Giannetta, Elisa; Guarnotta, Valentina; Rota, Francesca; de Cicco, Federica; Grillo, Federica; Colao, Annamaria; Faggiano, Antongiulio.

In: Critical Reviews in Oncology/Hematology, Vol. 137, 01.05.2019, p. 92-107.

Research output: Contribution to journalArticle

Giannetta, E, Guarnotta, V, Rota, F, de Cicco, F, Grillo, F, Colao, A & Faggiano, A 2019, 'A rare rarity', Critical Reviews in Oncology/Hematology, vol. 137, pp. 92-107. https://doi.org/10.1016/j.critrevonc.2019.02.012
Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A et al. A rare rarity. Critical Reviews in Oncology/Hematology. 2019 May 1;137:92-107. https://doi.org/10.1016/j.critrevonc.2019.02.012
Giannetta, Elisa ; Guarnotta, Valentina ; Rota, Francesca ; de Cicco, Federica ; Grillo, Federica ; Colao, Annamaria ; Faggiano, Antongiulio. / A rare rarity. In: Critical Reviews in Oncology/Hematology. 2019 ; Vol. 137. pp. 92-107.
@article{936208c1289942bc9ebd8a154a407808,
title = "A rare rarity",
abstract = "Esophageal Neuroendocrine tumors (NETs) are rare, aggressive and lacking specific symptoms. This causes a diagnostic delay, worsening the prognosis. Numerous cases are reported in literature, without a consensus on the management. Our aim was to clarify epidemiology, clinical presentation, diagnostic, therapeutic management of esophageal NETs. Extensive literature search identified a total of 226 articles. One hundred twenty-five articles (n = 1676) met the inclusion criteria, showing that: the incidence of esophageal NET varies geographically; men (60–70 years) are more affected; smoking and alcohol abuse are the major risk factors; dysphagia, weight loss, appetite loss are the most common clinical features. The histotypes include high-grade small and large cell esophageal carcinomas and low-grade carcinoid tumors. Mixed neuroendocrine/non-neuroendocrine neoplasms are the most common. Often the diagnosis occurs randomly on endoscopic examination. Circulating markers, functional combined with conventional imaging contributes to the diagnosis and management. Treatment depends on type, grade and stage of the tumor.",
keywords = "Esophageal NEC, Gastroenteropancreatic NET, Large cell esophageal NEN, MANEC, Small cell carcinoma",
author = "Elisa Giannetta and Valentina Guarnotta and Francesca Rota and {de Cicco}, Federica and Federica Grillo and Annamaria Colao and Antongiulio Faggiano",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.critrevonc.2019.02.012",
language = "English",
volume = "137",
pages = "92--107",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - A rare rarity

AU - Giannetta, Elisa

AU - Guarnotta, Valentina

AU - Rota, Francesca

AU - de Cicco, Federica

AU - Grillo, Federica

AU - Colao, Annamaria

AU - Faggiano, Antongiulio

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Esophageal Neuroendocrine tumors (NETs) are rare, aggressive and lacking specific symptoms. This causes a diagnostic delay, worsening the prognosis. Numerous cases are reported in literature, without a consensus on the management. Our aim was to clarify epidemiology, clinical presentation, diagnostic, therapeutic management of esophageal NETs. Extensive literature search identified a total of 226 articles. One hundred twenty-five articles (n = 1676) met the inclusion criteria, showing that: the incidence of esophageal NET varies geographically; men (60–70 years) are more affected; smoking and alcohol abuse are the major risk factors; dysphagia, weight loss, appetite loss are the most common clinical features. The histotypes include high-grade small and large cell esophageal carcinomas and low-grade carcinoid tumors. Mixed neuroendocrine/non-neuroendocrine neoplasms are the most common. Often the diagnosis occurs randomly on endoscopic examination. Circulating markers, functional combined with conventional imaging contributes to the diagnosis and management. Treatment depends on type, grade and stage of the tumor.

AB - Esophageal Neuroendocrine tumors (NETs) are rare, aggressive and lacking specific symptoms. This causes a diagnostic delay, worsening the prognosis. Numerous cases are reported in literature, without a consensus on the management. Our aim was to clarify epidemiology, clinical presentation, diagnostic, therapeutic management of esophageal NETs. Extensive literature search identified a total of 226 articles. One hundred twenty-five articles (n = 1676) met the inclusion criteria, showing that: the incidence of esophageal NET varies geographically; men (60–70 years) are more affected; smoking and alcohol abuse are the major risk factors; dysphagia, weight loss, appetite loss are the most common clinical features. The histotypes include high-grade small and large cell esophageal carcinomas and low-grade carcinoid tumors. Mixed neuroendocrine/non-neuroendocrine neoplasms are the most common. Often the diagnosis occurs randomly on endoscopic examination. Circulating markers, functional combined with conventional imaging contributes to the diagnosis and management. Treatment depends on type, grade and stage of the tumor.

KW - Esophageal NEC

KW - Gastroenteropancreatic NET

KW - Large cell esophageal NEN

KW - MANEC

KW - Small cell carcinoma

U2 - 10.1016/j.critrevonc.2019.02.012

DO - 10.1016/j.critrevonc.2019.02.012

M3 - Article

VL - 137

SP - 92

EP - 107

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -